Delivery Order SPE2DB25D3201-SPE2DB25FNTQN
Award Date 6/3/25
Potential Completion Date 6/25/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,305.14 for IMFINZI 500 mg/10 ml vials on August 25, 2025, with completion anticipated by September 16, 2025. This firm fixed price delivery order, which carries no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of IMFINZI 500 mg/10 ml vials with a ceiling value of $53,051.40 and a firm fixed price contract type. The order is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $15,420.00 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of 4564933251 IMFINZI 500 MG/10 ML VIAL 10ML, with a period of performance through July 10, 2024. This Delivery Order contract is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to...
- The Defense Logistics Agency awarded a delivery order valued at $26,525.70 to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This firm fixed-price delivery order, with a completion date of June 17, 2025, represents a pediatric pharmaceutical supply requirement to support federal medical procurement needs. The award was competitively procured with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,903.44 for IMFINZI (120 mg/2.4 mL vials), an oncology pharmaceutical product. This firm fixed-price, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of September 16, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,952.92 firm fixed-price delivery order contract is for the supply of IMFINZI 500 mg/10 ml vials, a specialty oncology medication. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $26,525.70 delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 27, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this award. This delivery order represents a task order under AmerisourceBergen's significant...
- The Defense Logistics Agency awarded a delivery order valued at $5,305.14 to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of June 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $31,830.84 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This firm fixed-price delivery order, with completion targeted for September 4, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,830.84 delivery order is for IMFINZI 500 MG/10 ML VIAL 10ML, a type of medical supply. The contract has an ultimate completion date of July 16, 2025 and is a firm fixed-price agreement. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...